HCA Insider Trading
HCA Healthcare, Inc. | Services-General Medical & Surgical Hospitals, NEC
Comprehensive Trading Performance Summary
The investment history of corporate insiders at HCA Healthcare, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-General Medical & Surgical Hospitals, NEC sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2023-02-02 04:03 | 2023-02-01 | Paslick P. Martin | Officer - SVP and CIO | SELL | $256.95 | 1,000 | $256,949 | 3,000 | -25.0% |
| 2023-02-02 03:57 | 2023-02-01 | Foster Jon M | Officer - EVP and COO | OPT+S | $251.98 | 16,424 | $4,138,480 | 10,938 | 0.0% |
| 2022-11-16 01:38 | 2022-11-11 | MOORE A BRUCE JR | Officer - Group President - Service Line | SELL | $224.07 | 10,000 | $2,240,690 | 30,807 | -24.5% |
| 2022-11-02 01:30 | 2022-10-28 | Sowell Joseph A III | Officer - SVP; Chief Development Officer | SELL | $223.18 | 12,946 | $2,889,304 | 0 | -100.0% |
| 2022-11-02 01:32 | 2022-10-28 | Hall Charles J | Officer - Group President | OPT+S | $223.50 | 9,838 | $2,198,793 | 199,883 | 0.0% |
| 2022-10-29 01:07 | 2022-10-28 | Billington Phillip G | Officer - SVP-Internal Audit Services | OPT+S | $222.58 | 8,332 | $1,854,518 | 40,652 | 0.0% |
| 2022-10-27 01:22 | 2022-10-24 | Torres Kathryn A. | Officer - SVP-Payer Contracting & Align. | SELL | $203.30 | 2,000 | $406,605 | 20,372 | -8.9% |
| 2022-07-28 03:16 | 2022-07-25 | Elcan Patricia F | 10% owner | BUY | $198.66 | 325 | $64,565 | 89,337 | +0.4% |
| 2022-05-18 00:40 | 2022-05-13 | Berres Jennifer | Officer - SVP & Chief Human Res. Officer | SELL | $218.87 | 2,358 | $516,086 | 11,392 | -17.1% |
| 2022-05-06 00:05 | 2022-05-03 | Whalen Kathleen M | Officer - SVP & Chief Ethics Officer | SELL | $215.38 | 500 | $107,690 | 11,373 | -4.2% |
| 2022-05-05 00:52 | 2022-05-02 | FRIST THOMAS F JR | 10% owner | BUY | $211.93 | 89,100 | $18,882,999 | 478,955 | +22.9% |
| 2022-05-04 00:59 | 2022-04-29 | McAlevey Michael R | Officer - SVP & Chief Legal Officer | BUY | $218.56 | 1,110 | $242,602 | 1,110 | +100.0% |
| 2022-05-03 01:01 | 2022-04-28 | Smith Andrea B | Director | BUY | $213.63 | 1,160 | $247,815 | 2,239 | +107.5% |
| 2022-03-16 01:33 | 2022-03-11 | Sowell Joseph A III | Officer - SVP; Chief Development Officer | SELL | $269.00 | 11,522 | $3,099,418 | 17,051 | -40.3% |
| 2022-02-19 02:47 | 2022-02-16 | MOORE A BRUCE JR | Officer - Group President - Service Line | SELL | $246.87 | 30,000 | $7,406,187 | 91,788 | -24.6% |
| 2022-01-07 02:38 | 2022-01-04 | Sowell Joseph A III | Officer - SVP; Chief Development Officer | OPT+S | $259.23 | 22,198 | $5,754,390 | 12,357 | 0.0% |
| 2021-11-13 01:28 | 2021-11-10 | Reiner Deborah M | Officer - SVP - Mktg. & Communications | SELL | $246.23 | 2,052 | $505,261 | 4,524 | -31.2% |
| 2021-11-13 01:26 | 2021-11-09 | Englebright Jane D. | Officer - SVP and Chief Nursing Officer | SELL | $249.61 | 3,364 | $839,689 | 0 | -100.0% |
| 2021-11-13 01:27 | 2021-11-11 | Foster Jon M | Officer - Group President | OPT+S | $241.64 | 16,294 | $3,937,298 | 0 | 0.0% |
| 2021-11-11 03:03 | 2021-11-10 | Billington Phillip G | Officer - SVP-Internal Audit Services | OPT+S | $246.26 | 8,252 | $2,032,096 | 37,109 | 0.0% |
| 2021-11-10 03:02 | 2021-11-05 | Wyatt Christopher F. | Officer - SVP & Controller | SELL | $252.94 | 2,100 | $531,174 | 27,820 | -7.0% |
| 2021-11-06 01:25 | 2021-11-03 | RUTHERFORD BILL B | Officer - CFO and EVP | SELL | $250.00 | 30,000 | $7,500,000 | 58,009 | -34.1% |
| 2021-11-05 01:22 | 2021-11-04 | Whalen Kathleen M | Officer - SVP & Chief Ethics Officer | OPT+S | $250.48 | 3,815 | $955,598 | 8,877 | 0.0% |
| 2021-11-03 02:34 | 2021-11-02 | HAZEN SAMUEL N | Director, Officer - CEO | OPT+S | $251.72 | 50,000 | $12,586,225 | 323,664 | 0.0% |
| 2021-08-10 00:33 | 2021-08-05 | Englebright Jane D. | Officer - SVP and Chief Nursing Officer | SELL | $250.12 | 4,018 | $1,004,997 | 0 | -100.0% |
| 2021-08-06 02:16 | 2021-08-03 | Cuffe Michael S. | Officer - President-Physician Services | SELL | $251.91 | 2,500 | $629,775 | 17,914 | -12.2% |
| 2021-08-05 04:02 | 2021-08-02 | Hall Charles J | Officer - Group President | SELL | $252.27 | 9,000 | $2,270,460 | 194,870 | -4.4% |
| 2021-08-05 04:11 | 2021-08-02 | Perlin Jonathan B | Officer - Pres-Clinical Operations & CMO | SELL | $250.00 | 40,000 | $10,000,008 | 44,348 | -47.4% |
| 2021-08-04 02:26 | 2021-07-30 | Englebright Jane D. | Officer - SVP and Chief Nursing Officer | SELL | $249.45 | 3,309 | $825,425 | 4,018 | -45.2% |
| 2021-07-30 01:32 | 2021-07-29 | Englebright Jane D. | Officer - SVP and Chief Nursing Officer | OPT+S | $249.36 | 200 | $49,872 | 7,327 | 0.0% |
| 2021-07-30 01:34 | 2021-07-27 | Paslick P. Martin | Officer - SVP and CIO | SELL | $250.00 | 7,466 | $1,866,500 | 12,878 | -36.7% |
| 2021-07-30 01:33 | 2021-07-27 | Hall Charles J | Officer - Group President | SELL | $249.94 | 3,000 | $749,820 | 203,870 | -1.5% |
| 2021-07-27 01:15 | 2021-07-22 | Whalen Kathleen M | Officer - SVP & Chief Ethics Officer | SELL | $246.90 | 886 | $218,752 | 8,877 | -9.1% |
| 2021-07-24 02:10 | 2021-07-21 | Torres Kathryn A. | Officer - SVP-Payer Contracting & Align. | SELL | $252.00 | 1,000 | $252,000 | 15,899 | -5.9% |
| 2021-05-14 02:42 | 2021-05-11 | Reiner Deborah M | Officer - SVP - Mktg. & Communications | SELL | $208.33 | 3,432 | $714,989 | 6,576 | -34.3% |
| 2021-05-07 02:55 | 2021-05-06 | Paslick P. Martin | Officer - SVP and CIO | OPT+S | $207.55 | 7,672 | $1,592,324 | 12,878 | 0.0% |
| 2021-05-06 03:02 | 2021-05-03 | Torres Kathryn A. | Officer - SVP-Payer Contracting & Align. | SELL | $204.32 | 2,417 | $493,843 | 16,899 | -12.5% |
| 2021-05-06 03:05 | 2021-05-03 | WATERMAN ROBERT A | Officer - SVP & General Counsel | SELL | $206.22 | 81,253 | $16,755,872 | 50,062 | -61.9% |
| 2021-05-06 03:01 | 2021-05-03 | MOORE A BRUCE JR | Officer - Group President - Service Line | SELL | $205.32 | 12,000 | $2,463,842 | 102,381 | -10.5% |
| 2021-05-05 02:42 | 2021-05-04 | Wyatt Christopher F. | Officer - SVP & Controller | OPT+S | $204.00 | 4,604 | $939,216 | 27,747 | 0.0% |
| 2021-05-04 02:38 | 2021-04-29 | Cuffe Michael S. | Officer - President-Physician Services | OPT+S | $201.53 | 18,664 | $3,761,384 | 20,369 | 0.0% |
| 2021-05-01 03:37 | 2021-04-28 | WATERMAN ROBERT A | Officer - SVP & General Counsel | SELL | $200.68 | 147,534 | $29,607,551 | 131,315 | -52.9% |
| 2021-04-28 03:19 | 2021-04-23 | Perlin Jonathan B | Officer - Pres-Clinical Operations & CMO | OPT+S | $200.00 | 100,695 | $20,138,849 | 25,514 | 0.0% |
| 2021-04-21 03:15 | 2021-04-20 | Foster Jon M | Officer - Group President | OPT+S | $194.90 | 5,504 | $1,072,730 | 9,838 | 0.0% |
| 2021-03-11 03:13 | 2021-03-10 | Foster Jon M | Officer - Group President | OPT+S | $186.18 | 5,432 | $1,011,330 | 9,838 | 0.0% |
| 2021-03-11 03:15 | 2021-03-08 | Riley Wayne Joseph | Director | SELL | $190.00 | 1,650 | $313,500 | 10,819 | -13.2% |
| 2021-02-26 03:31 | 2021-02-23 | Englebright Jane D. | Officer - SVP and Chief Nursing Officer | SELL | $174.75 | 5,751 | $1,005,014 | 3,509 | -62.1% |
| 2021-02-26 03:33 | 2021-02-24 | WATERMAN ROBERT A | Officer - SVP & General Counsel | SELL | $176.75 | 73,853 | $13,053,333 | 278,849 | -20.9% |
| 2021-02-23 04:37 | 2021-02-19 | Berres Jennifer | Officer - SVP & Chief Human Res. Officer | SELL | $176.05 | 6,692 | $1,178,127 | 3,380 | -66.4% |
| 2021-02-23 04:48 | 2021-02-19 | Wyatt Christopher F. | Officer - SVP & Controller | SELL | $177.06 | 3,200 | $566,580 | 28,180 | -10.2% |
How to Interpret $HCA Trades
Not every insider transaction in HCA Healthcare, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $HCA shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for HCA
Insider activity data for HCA Healthcare, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $HCA, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.